Who’s Hired? Apotex Names New US President & CEO

Viatris Appoints Head Of Capital Markets; Akorn Has A Fresh Board

As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles. 

Microscope_man
Apotex, Viatris, Akorn, Stada and Siegfried fill key leadership positions • Source: Shutterstock

Apotex Inc. has announced the appointment of Peter Hardwick as president and CEO of the Canadian generics giant’s US Apotex Corp unit, effective immediately. Most recently, Hardwick has served in an interim leadership role at Apotex Corp, “helping to navigate the business through unprecedented challenges created by the pandemic,” having been with Apotex for 14 years.

Jeff Watson, global president and CEO of Apotex commented that Hardwick’s “track record as a commercial executive in the pharmaceutical...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin